See also this year's filing and all EDGAR filings for this company.
PDF Report 0001736243_2022_Acurx_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Assets" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 9376706, 'exp_sum': 0, 'exp_to_value': {'AssetsCurrent': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 0, 'remainder_Assets': 0}} |
Graph
Absolute values for 0001736243, Acurx Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 13,254,150 |
| 4 | LiabilitiesCurrent | 843,909 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,784,023 |
| 9 | ResearchAndDevelopmentExpense | 2,030,177 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 66,503 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,254,150 |
| 1 | Liabilities | 843,909 |
| 2 | Expenses | 12,814,200 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 12,410,241 |
| 5 | NetIncome | -12,747,697 |
| 6 | ComprehensiveNetIncome | -12,747,697 |
| 7 | BaseVar | 13,489,381 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.03 |
| 9 | EconomicCapitalRatio | 3.04 |
Edgar->Model Mapping
Feature Distribution
